-
EP2266588
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2266588
| EP2266588 - Method for cancer therapy based on co-administration of a parovirus and a cytokine [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 25.11.2011 Database last updated on 20.07.2024 | Most recent event Tooltip | 25.11.2011 | Application deemed to be withdrawn | published on 28.12.2011 [2011/52] | Applicant(s) | For all designated states Deutsches Krebsforschungszentrum - Stiftung des öffentlichen Rechts / Universität Heidelberg Im Neuenheimer Feld 280 69120 Heidelberg / DE | For all designated states Ruprecht-Karls-Universität Heidelberg Grabengasse 1 69117 Heidelberg / DE | [N/P] |
| Former [2010/52] | For all designated states Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Im Neuenheimer Feld 280 69120 Heidelberg / DE | ||
| For all designated states Ruprecht-Karls-Universität Heidelberg Grabengasse 1 69117 Heidelberg / DE | Inventor(s) | 01 /
Kiprijanova, Irina Furtwängler-Str. 3 69121 Heidelberg / DE | 02 /
Fischer, Manuel Almstr. 26 69151 Neckargemünd / DE | 03 /
Rommelaere, Jean Schloß-Wolfsbrunnenweg 11 69118 Heidelberg / DE | 04 /
Schlehofer, Jörg Feilgasse 14 69181 Leimen / DE | 05 /
Geletneky, Karsten Max-Wolf-Str. 9 69120 Heidelberg / DE | [2010/52] | Representative(s) | Schüssler, Andrea Kanzlei Huber & Schüssler Truderinger Strasse 246 81825 München / DE | [N/P] |
| Former [2010/52] | Schüssler, Andrea Kanzlei Huber & Schüssler Truderinger Strasse 246 81825 München / DE | Application number, filing date | 09007433.7 | 04.06.2009 | [2010/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2266588 | Date: | 29.12.2010 | Language: | EN | [2010/52] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 18.11.2009 | Classification | IPC: | A61K35/76, A61K38/21, A61K35/00 | [2010/52] | CPC: |
A61K35/768 (EP,US);
A61K38/217 (EP,US);
A61P35/00 (EP);
A61P43/00 (EP);
C12N7/00 (US);
C12N2750/14332 (EP,US);
| C-Set: |
A61K35/768, A61K2300/00 (EP,US);
A61K38/217, A61K2300/00 (US,EP) | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/52] | Extension states | AL | Not yet paid | BA | Not yet paid | RS | Not yet paid | Title | German: | Verfahren zur Krebstherapie basierend auf der gleichzeitigen Verabreichung eines Parvovirus und eines Zytokins | [2010/52] | English: | Method for cancer therapy based on co-administration of a parovirus and a cytokine | [2010/52] | French: | Procédé de thérapie de cancer à base de co-administration de paroviruet de cyokine | [2010/52] | Examination procedure | 30.06.2011 | Application deemed to be withdrawn, date of legal effect [2011/52] | 08.08.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2011/52] | Fees paid | Penalty fee | Additional fee for renewal fee | 30.06.2011 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]US5952221 (KURTZMAN GARY J [US], et al) [X] 1-3,5-8,14,15 * column 1, lines 14-22; claims 1,3 * * column 6, lines 42-52 * * column 20, lines 37-41 *; | [X]WO0022151 (DEUTSCHES KREBSFORSCH [DE], et al) [X] 1,5,8,12,13,15 * page 4, paragraph 3; claims 1,6,11,19,20 *; | [X]US2004029106 (SAMULSKI RICHARD JUDE [US], et al) [X] 1-8,14,15 * paragraphs [0167] , [0168] , [0172]; claims 69,70,84,86 *; | [Y] - GIESE NATHALIA A ET AL, "Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice.", CANCER GENE THERAPY MAY 2002, (200205), vol. 9, no. 5, ISSN 0929-1903, pages 432 - 442, XP002554188 [Y] 1,5,8,12-15 * page 434, column R, paragraph 1 * * page 442, column L, paragraphs 2,3 * DOI: http://dx.doi.org/10.1038/sj.cgt.7700457 | [Y] - HAAG ANDREAS ET AL, "Highly efficient transduction and expression of cytokine genes in human tumor cells by means of autonomous parvovirus vectors; generation of antitumor responses in recipient mice", HUMAN GENE THERAPY, (20000301), vol. 11, no. 4, ISSN 1043-0342, pages 597 - 609, XP002554189 [Y] 1-15 * the whole document * DOI: http://dx.doi.org/10.1089/10430340050015789 | [Y] - ENDERLIN M ET AL, "TNF-alpha and the IFN-gamma-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma", CANCER GENE THERAPY, (200902), vol. 16, no. 2, ISSN 0929-1903, pages 149 - 160, XP002554228 [Y] 1-15 * the whole document * DOI: http://dx.doi.org/10.1038/cgt.2008.62 | [Y] - ANETTE ABSCHUETZ ET AL, "Oncolytic murine autonomous parvovirus, a candidate vector for glioma gene therapy, is innocuous to normal and immunocompetent mouse glial cells", CELL AND TISSUE RESEARCH, SPRINGER, BERLIN, DE, (20060503), vol. 325, no. 3, ISSN 1432-0878, pages 423 - 436, XP019428267 [Y] 1-15 * the whole document * DOI: http://dx.doi.org/10.1007/s00441-006-0199-z | [Y] - ANGELOVA ASSIA L ET AL, "Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studies.", MOLECULAR THERAPY : THE JOURNAL OF THE AMERICAN SOCIETY OF GENE THERAPY JUL 2009, (20090414), vol. 17, no. 7, ISSN 1525-0024, pages 1164 - 1172, XP009125443 [Y] 1-15 * the whole document * DOI: http://dx.doi.org/10.1038/mt.2009.78 | by applicant | - FINGL ET AL., The Pharmocological Basis of Therapeutics, MACMILLAN PUBLISHING CO, (1975), pages 1 - 46 | - RUSSELL ET AL., J VIROL, (1992), vol. 66, pages 2821 - 8 |